Edition:
United Kingdom

People: Molecular Medicine SpA (MLMD.MI)

MLMD.MI on Milan Stock Exchange

0.36EUR
21 Sep 2018
Change (% chg)

€0.00 (+0.84%)
Prev Close
€0.36
Open
€0.36
Day's High
€0.37
Day's Low
€0.36
Volume
1,037,053
Avg. Vol
1,753,655
52-wk High
€0.60
52-wk Low
€0.34

Lambiase, Antonio 

Dr. Antonio Lambiase serves as Director of Clinical Development at Molecular Medicine S.p.A. since March 2007. He previously worked for over 15 years at Roche in the areas of oncology and hematology as Medical Responsible for Clinical Development of several biological and molecular targeted compounds, including cancer bio therapeutics, hematopoietic growth factors, and therapeutic monoclonal antibodies and antiangiogenesis agents. Before that, he spent three years as Research Fellow at the Medical Oncology Unit of National Cancer Institute of Milan. He gained a degree in Medicine from Universita degli Studi di Napoli Federico II and a Doctorate of Medicine in Medicine from Universita degli Studi di Napoli Federico II.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --